FDA OKs Linaclotide in Young Children - Top-Institutions - MDSpire

FDA OKs Linaclotide in Young Children

Phase 3 data expanded use of linaclotide 72 mcg in pediatric functional constipation.

  • By

  • Kathryn Wighton

  • May 27, 2026

  • 2 min

Share

Top Institutions in Pediatrics

Brief introduction explaining scope and methodology.

  • #1

    Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and Surgeons

    New York, NY

    Key Differentiators

    • Pediatrics
    • Gastroenterology

  • #2

    National University Hospital
    National University Hospital

    Singapore, SG

    Key Differentiators

    • Pediatrics
    • Hematology-Oncology

  • #3

    BCHILD trial
    BCHILD trial

    N/A, N/A

    Key Differentiators

    • Pediatrics

Original Source(s)

FDA OKs Linaclotide in Young Children

  • by Kathryn Wighton

  • May 27, 2026

Related Content

Usefulness of ultrasound in diagnosing constipation in children: a narrative review

Vitamin D May Reflect Myopia Risk

Narrative review linked lower vitamin D levels to greater myopia risk and higher omega-3 intake to lower risk, though outdoor exposure may explain the vitamin D association.

Partly intraoperative cell salvage in pediatric craniocerebral trauma: effects on coagulation function, allogeneic blood requirements, and clinical outcomes — a propensity score-matched retrospective cohort study